All News about Biogen Idec
![](https://g.foolcdn.com/editorial/images/716579/senior-person-eye-to-eye-with-younger-person.jpg)
![](https://g.foolcdn.com/editorial/images/715262/two-investors-work-at-a-table-with-a-laptop-and-a-phone.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://g.foolcdn.com/editorial/images/715647/scientists-looking-at-brain-scans.jpg)
![](https://g.foolcdn.com/editorial/images/714838/doctor-and-patient-talking.jpg)
![](https://g.foolcdn.com/editorial/images/714222/a-group-of-scientists-looking-at-a-report.jpg)
![](https://g.foolcdn.com/editorial/images/714017/gettyimages-scientist_computer_others-in-background.jpg)
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2023/01/07/woman_readin_newspaper.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/lgvn_logo_light__f5b12fd117c70d6903f273aa72ad2964.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/dementia-3051832_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/06/biogen.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/06/biogen-biib.jpg)
![](https://cdn.pixabay.com/photo/2014/12/10/20/48/medic-563425_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_42.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-biogen-10-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/715097/patient-taking-medicine.jpg)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/715079/advisor-reviewing-data-on-a-laptop-with-a-family.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
From Biogen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/29/medicine-g6bfa601b6_1920.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-Lab01-company.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_10893825_S.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/27/photo_by_nednapa_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/roche.png?width=1200&height=800&fit=crop)
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/713443/businessman-with-a-chart-looking-at-his-computer.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/biib_logo_light__74da60da9d9119bf81bd30b84737bd7a.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/713567/doctor-holding-elderly-patients-hand.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.